Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 29, 2024 |
Dec. 29, 2023 |
Mar. 31, 2023 |
Dec. 30, 2022 |
Mar. 29, 2024 |
Mar. 31, 2023 |
|
| Change in Accounting Estimate [Line Items] | ||||||
| Decrease in depreciation expense | $ 130.0 | $ 198.4 | ||||
| Decrease in cost of goods sold | $ 625.7 | $ 625.7 | 1,320.7 | 1,317.4 | ||
| Decrease in research and development | 154.4 | 148.2 | 307.3 | 312.0 | ||
| Increase in net income | $ 183.3 | $ 231.3 | $ 232.8 | $ 309.4 | $ 414.6 | $ 542.2 |
| Increase in diluted EPS (in dollars per share) | $ 1.14 | $ 1.46 | $ 2.57 | $ 3.39 | ||
| Change in useful life | ||||||
| Change in Accounting Estimate [Line Items] | ||||||
| Increase in useful life | 2 years | 2 years | ||||
| Decrease in depreciation expense | $ 18.9 | $ 37.7 | ||||
| Decrease in cost of goods sold | 1.8 | 1.8 | ||||
| Decrease in research and development | 2.5 | 4.9 | ||||
| Decrease in ending inventory | 31.0 | 31.0 | ||||
| Increase in net income | $ 4.3 | $ 6.7 | ||||
| Increase in diluted EPS (in dollars per share) | $ 0.03 | $ 0.04 | ||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|